CA3185973A1 - Polymorphs of a hydrochloride salt of pn6047 - Google Patents
Polymorphs of a hydrochloride salt of pn6047Info
- Publication number
- CA3185973A1 CA3185973A1 CA3185973A CA3185973A CA3185973A1 CA 3185973 A1 CA3185973 A1 CA 3185973A1 CA 3185973 A CA3185973 A CA 3185973A CA 3185973 A CA3185973 A CA 3185973A CA 3185973 A1 CA3185973 A1 CA 3185973A1
- Authority
- CA
- Canada
- Prior art keywords
- salt
- crystalline
- pain
- radiation
- xrpd pattern
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE2050910 | 2020-07-17 | ||
| SE2050910-5 | 2020-07-17 | ||
| PCT/EP2021/069340 WO2022013153A1 (en) | 2020-07-17 | 2021-07-12 | Polymorphs of a hydrochloride salt of pn6047 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3185973A1 true CA3185973A1 (en) | 2022-01-20 |
Family
ID=77168220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3185973A Pending CA3185973A1 (en) | 2020-07-17 | 2021-07-12 | Polymorphs of a hydrochloride salt of pn6047 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230174525A1 (https=) |
| EP (1) | EP4182312A1 (https=) |
| JP (2) | JP2023533874A (https=) |
| CN (1) | CN116171277B (https=) |
| AU (1) | AU2021309364A1 (https=) |
| CA (1) | CA3185973A1 (https=) |
| WO (1) | WO2022013153A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0103313D0 (sv) * | 2001-10-03 | 2001-10-03 | Astrazeneca Ab | Novel compounds |
| US20110207745A1 (en) * | 2009-11-25 | 2011-08-25 | Astrazeneca Ab | Solid forms of 4--n,n-diethylbenzamide, compositions thereof, and uses therewith |
| CA2970256C (en) * | 2014-12-19 | 2022-03-29 | Pharmnovo Ab | Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists |
-
2021
- 2021-07-12 WO PCT/EP2021/069340 patent/WO2022013153A1/en not_active Ceased
- 2021-07-12 CA CA3185973A patent/CA3185973A1/en active Pending
- 2021-07-12 CN CN202180060408.6A patent/CN116171277B/zh active Active
- 2021-07-12 US US18/015,828 patent/US20230174525A1/en active Pending
- 2021-07-12 EP EP21749114.1A patent/EP4182312A1/en active Pending
- 2021-07-12 AU AU2021309364A patent/AU2021309364A1/en active Pending
- 2021-07-12 JP JP2023503146A patent/JP2023533874A/ja active Pending
-
2025
- 2025-10-06 JP JP2025168607A patent/JP2026016435A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023533874A (ja) | 2023-08-04 |
| CN116171277B (zh) | 2026-03-06 |
| CN116171277A (zh) | 2023-05-26 |
| JP2026016435A (ja) | 2026-02-03 |
| EP4182312A1 (en) | 2023-05-24 |
| US20230174525A1 (en) | 2023-06-08 |
| AU2021309364A8 (en) | 2023-03-16 |
| AU2021309364A1 (en) | 2023-02-16 |
| WO2022013153A1 (en) | 2022-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250019363A1 (en) | Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate | |
| US12365680B2 (en) | Polymorphs of the hydrochloride salt of linaprazan glurate | |
| US20220002297A1 (en) | Polymorphs of x842 | |
| US20080234323A1 (en) | Amorphous and Three Crystalline Forms of Rimonabant Hydrochloride | |
| JP2018515566A (ja) | 医薬組成物 | |
| US20230174525A1 (en) | Polymorphs of a hydrochloride salt of pn6047 | |
| WO2007074477A2 (en) | Metaxalone polymorphs | |
| EP4649079A1 (en) | Polymorphs of the hydrobromide salt of linaprazan glurate | |
| WO2023079093A1 (en) | Polymorphs of the mesylate salt of linaprazan glurate | |
| HK40092799A (zh) | Pn6047盐酸盐的多晶型物 | |
| US20240228443A1 (en) | Novel manufacturing method of daprodustat and precursors thereof | |
| EP4649078A1 (en) | Polymorphs of the maleic acid salt of linaprazan glurate | |
| EP4103546A1 (en) | Polymorphs of elafibranor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20250617 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250617 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - SMALL Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250627 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250627 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250826 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20250826 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250827 |